Rami-Merhar, Birgit

Temporal Trends and Contemporary Use of Insulin Pump Therapy and Glucose Monitoring Among Children, Adolescents, and Adults With Type 1 Diabetes Between 1995 and 2017

van den Boom, L., Karges, B., Auzanneau, M., Rami-Merhar, B., Lilienthal, E., von Sengbusch, S., Datz, N., Schröder, C., Kapellen, T., Laimer, M., et al. (2019) · Diabetes Care

Diabetes Management and ResearchDiabetes Management and Education

Cited by 191

Managing diabetes in preschool children

Sundberg, F., Barnard, K., Cato, A., de Beaufort, C., DiMeglio, L. A., Dooley, G., Hershey, T., Hitchcock, J., Jain, V., Weissberg-Benchell, J., et al. (2017) · Pediatric Diabetes

Diabetes Management and ResearchDiabetes Management and Education

Cited by 91

Use of adjuvant pharmacotherapy in type 1 diabetes: international comparison of 49,996 individuals in the prospective diabetes follow-up and T1D exchange registries

Lyons, S. K., Hermann, J. M., Miller, K. M., Hofer, S. E., Foster, N. C., Rami-Merhar, B. M., Aleppo, G., Seufert, J., DiMeglio, L. A., Danne, T., et al. (2017) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 51

Association of insulin-manipulation and psychiatric disorders: a systematic epidemiological evaluation of adolescents with type 1 diabetes in Austria

Berger, G., Waldhoer, T., Barrientos, I., Kunkel, D., Rami-Merhar, B. M., Schober, E., Karwautz, A., & Wagner, G. (2019) · Pediatric Diabetes

Diabetes Management and EducationDiabetes Management and Research

Cited by 49

Minimum effective low dose of antithymocyte globulin in people aged 5–25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial

Mathieu, C., Wych, J., Hendriks, A. E. J., Van Ryckeghem, L., Tree, T., Chmura, P., Möller, C., Casteels, K., Danne, T., Reschke, F., et al. (2025) · The Lancet

Diabetes and associated disordersDiabetes Management and Research

Cited by 17